Novo Nordisk
· NVO
306 B
+2.94%
Growth
· FY
Rev. 1Y%
25.03%
RPS 3Y CAGR
28.60%
RPS 10Y CAGR
14.47%
EPS 1Y%
142.85%
EPS 3Y CAGR
29.68%
EPS 10Y CAGR
16.24%
Profitability
· FY
Gross Margin
84.33%
Op. Inc. Margin
44.53%
Profit Margin
34.51%
ROE
81.24%
ROA
21.39%
ROCE
53.34%
$71.5
306.34 B
0.00
0.00
2.14
0.00
0.00
Fundamental Charts
Earnings Per Share
Subscribe to unlock chart
Try Premium free for 7 days